A Study to Evaluate the Efficacy and Safety of BR1017A and BR1017B Combination Therapy in Essential Hypertension Patients With Primary Hypercholesterolemia

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The objective of this clinical study is to evaluate the efficacy and safety by comparing BR1017A+BR1017B treatment group to BR1017A treatment group and BR1017B treatment group respectively at Week 8 in essential hypertension patients with primary hypercholesterolemia
Epistemonikos ID: ad39cc09483160c5e4e7363b55c30f5c4d6da6dc
First added on: May 15, 2024